Skip to content
Screener

Medifast MED Q3 2025 earnings

Reported November 3, 2025 · After market close

Revenue$89.4MBeat by $18.0M
EPS-$0.21Miss by $0.20
Revenue estimate$71.4M
EPS estimate-$0.01

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$71.3M
EPS estimate-$0.35

Financials

Q3 2025

Income statement

See full
Revenue$89.4M-36.2%
Gross profit$62.2M-41.2%
Operating income-$4.1M-294%
Net income-$2.3M-300%
EPS (diluted)-$0.21-310%

Balance sheet

See full
Cash & equivalents$99.5M-13.7%
Total debt$12.3M-30.4%
Total equity$214.7M+3.6%
Total assets$268.2M-7.9%

Cash flow

See full
Operating cash flow$12.1M+33.5%
CapEx$1.4M-1.9%
Free cash flow$10.8M+39.9%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$150.25M-28.2%
Enterprise value$62.98M-43.6%
P/E605.8×+577×
P/S0.3×0.0×

Profitability

See full
Gross margin72.4%-1.4pp
Operating margin-1.3%-2.9pp
Net margin0.1%-1.0pp

Returns & leverage

See full
Return on equity0.1%-3.5pp
Debt / equity0.1×0.0×
Current ratio4.4×+1.3×

Segments

By segment

See full
Optavia Segment$89.4M-36.2%

FAQ

When did Medifast report Q3 2025 earnings?
Medifast (MED) reported Q3 2025 earnings on November 3, 2025 after market close.
What were Medifast's Q3 2025 revenue and EPS?
Medifast reported revenue of $89.4M and eps of $-0.21 for Q3 2025.
Did Medifast beat estimates in Q3 2025?
Revenue beat the consensus estimate of $71.4M by $18.0M. EPS missed the consensus estimate of $-0.01 by $0.20.
How did Medifast's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 36.2% from $140.2M a year earlier.
Where can I find Medifast's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-048251) and the 10-Q periodic report (0001628280-25-048332) directly on SEC EDGAR. The filing index links above go to sec.gov.